| 000 | 01006 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513094459.0 | ||
| 264 | 0 | _c19961024 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a1660-8151 | ||
| 024 | 7 |
_a10.1159/000189012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSegarra, A | |
| 245 | 0 | 0 |
_aLipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome. _h[electronic resource] |
| 260 |
_bNephron _c1996 |
||
| 300 |
_a102-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comment; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolysis _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoprotein(a) _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aChacón, P | |
| 700 | 1 | _aPiera, L L | |
| 773 | 0 |
_tNephron _gvol. 73 _gno. 1 _gp. 102-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000189012 _zAvailable from publisher's website |
| 999 |
_c8740026 _d8740026 |
||